Question 1

What is Terns Pharmaceuticals Inc (TERN) stock price today?

Accepted Answer

Terns Pharmaceuticals Inc (TERN) currently trades at $52.92 per share. The stock has a market capitalization of $6.11B and a P/E ratio of —x.

Question 2

Is TERN stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Terns Pharmaceuticals Inc has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is —.

Question 3

What is Terns Pharmaceuticals Inc's revenue and earnings?

Accepted Answer

Terns Pharmaceuticals Inc has trailing twelve-month (TTM) revenue of $1.00M with profit margins of 0.00%. Earnings per share (EPS) is $-1.03.

Question 4

Is Terns Pharmaceuticals Inc financially healthy?

Accepted Answer

Terns Pharmaceuticals Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of — places it in the —.

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$1.00M
Net income	$-60.34M	$-90.21M	$-88.85M	$-96.21M	$-23.57M
EPS	—	—	—	—	$-1.03
Free cash flow	$-49.38M	$-67.44M	$-70.06M	$-82.18M	$-19.08M
Profit margin	—	—	—	—	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TERN	$6.11B	25	4.3	3.0	5.0	7.3	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Terns Pharmaceuticals Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare